Advertisement

EUROPEAN Device Guide / Self-Expanding Stents

Company Name Product Name Material Used Introducer Size (F) Guidewire Compatibility (inch) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) CE Mark Indications
Abbott Absolute Pro LL Peripheral Stent Nitinol 6 0.035 5–8 120, 150 80, 135 Peripheral arteries as an adjunct to PTA and for the palliation of malignant strictures in the biliary tree
Abbott Absolute Pro Peripheral Stent Nitinol 6 0.035 5–10 20, 30, 40, 60, 80, 100 80, 135 Peripheral arteries as an adjunct to PTA and for the palliation of malignant strictures in the biliary tree
Biotronik AG Astron Nitinol 6 0.035 7, 8, 9, 10 30, 40, 60, 80 70, 120 Iliac artery
Biotronik AG Astron Pulsar Nitinol 4 0.018 4, 5, 6, 7 20, 30, 40, 60, 80 70–75, 120–135 Femoral and infrapopliteal arteries
Veryan Medical BioMimics 3D Self-Expanding Stent System Nitinol 6 0.035 5, 6, 7, 8 60, 80, 100, 125, 150 113 SFA, proximal popliteal
amg International GmbH ClaudEX Peripheral Self-Expandable Stent Nitinol 1.9 0.014 3.5, 4.5 15, 20, 25, 30, 35 200 Intended for use in the treatment of peripheral artery obstruction or in cases of insufficient results after PTA (eg, residual stenosis or dissection due to arteriosclerotic plaque material or restenosis)
BD Interventional E•Luminexx Biliary Stent Nitinol 6 0.035 8, 10 40, 60, 80, 100 60 Treatment of biliary strictures resulting from malignant neoplasms
BD Interventional E•Luminexx Vascular Stent Nitinol 6 0.035 4–10, 12, 14 20, 30, 40, 50, 60, 80, 100, 120 80, 135 Residual stenosis with impaired perfusion (pressure gradient) following balloon dilatation, especially in stages III and IV according to Fontaine; dissection; detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation; occlusion after thrombolysis or after aspiration and before dilatation; restenosis or reocclusion
Alvimedica Easy Flype Nitinol 6 0.035 6–8 20–150 85, 135 Peripheral
Alvimedica Easy HiFlype Nitinol 6 0.035 9–12 20–100 85, 135 Peripheral
Boston Scientific Corporation Epic Self-Expanding Nitinol Vascular Stent Nitinol 6 0.035 6–10, 12 20, 30, 40, 50, 60, 70, 80, 100, 120 75, 120 Iliac
Medtronic EverFlex Self-Expanding Peripheral Stent With Entrust Delivery System Nitinol 5 0.035 5–8 20, 40, 60, 80, 100, 120, 150 80, 120, 150 Biliary, peripheral
amg International GmbH Facile Self-Expandable Stent System Nitinol 6 0.035 6–11 20, 40, 60, 80, 100, 120, 150 80, 120 Peripheral arteries
amg International GmbH Facile-pp Self-Expandable Stent System Nitinol 6 0.035 6–11 20, 40, 60, 80, 100, 120, 150, 175, 200 80, 120 Peripheral arteries
Gore & Associates Gore Tigris Vascular Stent Nitinol/ePTFE 6 0.035 5, 6, 7 30, 40, 60, 80, 100 80, 120 Indicated for endovascular stenting of peripheral arteries
Gore & Associates Gore Tigris Vascular Stent Nitinol/ePTFE 7 0.035 8 30, 40, 60, 80, 100 80, 120 Indicated for endovascular stenting of peripheral arteries
Boston Scientific Corporation Innova Self-Expanding Stent System Nitinol 6 0.035 (0.89 mm) 5–8 20, 40, 60, 80, 100, 120, 150, 180, 200 75, 130 SFA, proximal popliteal
iVascular iVolution Nitinol 6 0.035 5, 6, 7, 8, 9, 10 40, 60, 80, 100, 150, 200 80, 140 Treatment of de novo or restenotic atherosclerotic lesions in peripheral arteries located below the aortic arch, and for palliation of malignant structures of the bile ducts with nominal diameter between 4.5–9.5 mm
Balton Jaguar Nitinol wire 6, 7, 8 0.018, 0.035 4–14 15–150 80, 135 Peripheral
BD Interventional Life Star Vascular Stent Nitinol 6 0.035 4–10, 12, 14 20, 30, 40, 50, 60, 80, 100, 120 80, 135 Residual stenosis with impaired perfusion (pressure gradient) following balloon dilatation, especially in stages III and IV according to Fontaine; dissection; detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation; occlusion after thrombolysis or after aspiration and before dilatation; restenosis or reocclusion
BD Interventional LifeStent 5F Vascular Stent Nitinol 5 0.035 5–7 20, 30, 40, 60, 80, 100, 120, 150, 170 (diameter dependent) 80, 135 Intended to improve luminal diameter in the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and popliteal artery
BD Interventional LifeStent Solo Vascular Stent Nitinol 6 0.035 6–7 200, 250 80, 100, 135 Intended to improve luminal diameter in the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and proximal popliteal artery
BD Interventional LifeStent Vascular Stent Nitinol 6 0.035 5–10 20, 30, 40, 60, 80, 100, 120, 150, 170, 200 (diameter dependent) 80, 130, 135 Intended for primary stenting of de novo or restenotic lesions of the peripheral arteries (20–170 mm); primary stenting of the SFA and/or the PPA (200 mm)
Natec Medical Ltd Marina Nitinol 6 0.035 5–10 30–200 80, 130 Peripheral and biliary
Micro Medical Solutions MicroStent Nitinol 4 0.014 3, 3.5, 4, 4.5 8, 15, 25, 40, 60 120 Indicated for treatment of peripheral artery disease and critical limb ischemia
QualiMed Innovative Medizinprodukte GmbH Peripheral Vascular Self-Expanding Stent System (PS) Nitinol 6 0.035 6–11 20, 40, 60, 80, 100, 120, 150 80, 120 Peripheral arteries
QualiMed Innovative Medizinprodukte GmbH Peripheral Vascular Self-Expanding Stent System (PSpp) Nitinol 6 0.035 6–11 20, 40, 60, 80, 100, 120, 150, 175, 200 80, 120 Peripheral arteries
Cordis, a Cardinal Health company Precise Pro RX Nitinol 5 (5–8-mm diameter), 6 (9–10-mm diameter) 0.014 5–10 20, 30, 40 135 Carotid
Medtronic Protégé EverFlex Self-Expanding Stent System Nitinol 6 0.035 5–8 20, 30, 40, 60, 80, 100, 120, 150, 200 80, 120 Biliary, peripheral
Medtronic Protégé GPS Self-Expanding Stent System Nitinol 6 0.035 9, 10, 12, 14 20, 30, 40, 60, 80 80, 120 Biliary, peripheral
Biotronik AG Pulsar-18 Nitinol 4 0.018 4, 5, 6, 7 20, 30, 40, 60, 80, 100, 120, 150, 170, 200 90, 135 Femoral and infrapopliteal arteries
Biotronik AG Pulsar-35 Nitinol 6 0.035 5, 6, 7 30, 40, 60, 80, 100, 120, 150, 170, 200 90, 135 Femoral and proximal popliteal arteries
eucatech AG Resistant Nitinol 0.035 4, 5, 6, 7, 8, 9, 10, 12 20, 30, 40, 60, 80, 100 85, 135 Treatment of SFA and popliteal artery stenosis
eucatech AG Resistant Camouflage Nitinol with camouflage nanocoating 0.035 5, 6, 7, 8 40, 60, 80, 100 135 Treatment of stenosis of peripheral vessels
QualiMed Innovative Medizinprodukte GmbH Self-Expandable Stent (BTK) Nitinol 1.9 0.014 3.5, 4.5 15, 20, 25, 30, 35 200 Intended for use in the treatment of peripheral artery obstruction or in cases of insufficient results after PTA (eg, residual stenosis or dissection due to arteriosclerotic plaque material or restenosis)
optimed Medizinische Instrumente GmbH sinus-Reduction Nitinol 10 0.035 14/4/14, 14/5/14 40 70 Reduction of blood flow after TIPS stent insertion
optimed Medizinische Instrumente GmbH sinus-Repo-DS Nitinol 4 0.018 5, 6 9 85 Aortic coarctation stenting in neonates
optimed Medizinische Instrumente GmbH sinus-Repo-Visual 6F Nitinol 6 0.035 6–10, 12, 14 20, 30, 40, 60, 80, 100 75, 120 Peripheral arteries
optimed Medizinische Instrumente GmbH sinus-SuperFlex-418 Nitinol 4 0.018 3–8 30, 40, 60, 80, 100, 130, 150, 180, 200 85, 135 Peripheral arteries
optimed Medizinische Instrumente GmbH sinus-SuperFlex-535 Nitinol 5 0.035 4–10 30, 40, 60, 80 75, 120 Peripheral arteries, biliary
optimed Medizinische Instrumente GmbH sinus-SuperFlex-635 Nitinol 6 0.035 6–10, 12 30, 40, 60, 80, 100, 120, 150 75, 120 Peripheral arteries, biliary
optimed Medizinische Instrumente GmbH sinus-SuperFlex-DS Nitinol 4 0.018 4–9 12, 15, 18, 20, 22, 24 85 Ductal stenting
optimed Medizinische Instrumente GmbH sinus-XL Nitinol 10 0.035 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36 30, 40, 60, 80, 100 100 Aorta and vena cava
optimed Medizinische Instrumente GmbH sinus-XL 6F Nitinol 6 0.035 14, 16 30, 40, 60, 80, 100 100 Aorta and vena cava
optimed Medizinische Instrumente GmbH sinus-XL Flex Nitinol 10 0.035 14, 16, 18, 20, 22, 24 40, 60, 80, 100, 120, 150, 160 100 Aorta, vena cava, and symptomatic obstructions of iliofemoral veins
Cordis, a Cardinal Health company SMART Control Nitinol 6 0.035 6–10, 12, 14 20, 30, 40, 60, 80, 100 80, 120 Vascular
Cordis, a Cardinal Health company SMART Flex Nitinol 6 0.035 5–8 30, 40, 60, 80, 100, 120, 150, 200 80, 120 SFA, proximal popliteal
Cordis, a Cardinal Health company SMART Flex Nitinol 6 0.035 9, 10 20, 30, 40, 50, 60, 70, 80, 90, 100 80, 120 Iliac
Abbott Supera Peripheral Stent System Interwoven nitinol wires 6 0.018 4.5–7.5 (OD) 20, 30, 40, 60, 80, 100, 120, 150, 180, 200 80, 120 Peripheral vascular
Intact Vascular Tack Endovascular System (4F) Nitinol with gold radiopaque markers 4 0.014 1.5–4.5 6 150 Intended for use in mid/distal popliteal, tibial, and peroneal arteries, ranging in diameter from 1.5 to 4.5 mm, for the treatment of dissection(s) requiring repair after percutaneous transluminal balloon angioplasty
Intact Vascular Tack Endovascular System (6F) Nitinol with gold radiopaque markers 6 0.035 2.5–6 6 120 Intended for use in the superficial femoral and proximal popliteal arteries ranging in diameter from 2.5 to 6 mm for the repair of dissection(s) type(s) A through F after percutaneous transluminal balloon angioplasty
Andramed GmbH U-Flex Nitinol Stent Nitinol 6 0.035 5–10 20, 30, 40, 50, 60, 80, 100, 120, 150, 180, 200 80, 130 Peripheral
Andramed GmbH U-Flex Nitinol Stent Nitinol 5 0.018 5–10 15, 30, 40, 50, 60, 80, 100, 120, 150, 180, 200 80, 120 Peripheral
B. Braun Melsungen AG VascuFlex 5F Nitinol 5 0.018 5, 6, 7, 8, 9, 10 20, 40, 60, 80, 100, 120, 150, 180, 200 80, 120 Peripheral; indicated for atherosclerotic diseases of the peripheral arteries (eg, A. iliaca, A. femoralis, and A. femoralis superficialis) and in other vessels which correspond in their anatomic dimensions to the available sizes of stents; treatment of bile duct strictures
B. Braun Melsungen AG VascuFlex 5F TR/TB Nitinol 5 0.018 6, 7, 8 40, 60, 80 180 For transradial and transbrachial approach indicated for atherosclerotic diseases of the peripheral arteries (eg, A. iliaca, A. femoralis, and A. femoralis superficialis) and in other vessels which correspond in their anatomic dimensions to the available sizes of stents
B. Braun Melsungen AG VascuFlex 6F Nitinol 6 0.035 5, 6, 7, 8, 9, 10 20, 40, 60, 80, 100, 120, 150, 180, 200 80, 130 Peripheral; indicated for atherosclerotic diseases of the peripheral arteries (eg, A. iliaca, A. femoralis, and A. femoralis superficialis) and in other vessels which correspond in their anatomic dimensions to the available sizes of stents; treatment of bile duct strictures
B. Braun Melsungen AG VascuFlex Aortic Nitinol 12, 14, 16 0.035 14, 16, 18, 20, 22, 24, 28, 32, 36, 40 70, 100, 130, 150 100 Indicated for the treatment of dissections, stenoses, and other specific lesions of the thoracic descending aorta, the abdominal aorta, as well as for the treatment of vena-cava syndrome
B. Braun Melsungen AG VascuFlex Multi-LOC (MSDS) Nitinol 6 0.035 5, 6, 7, 8 13 (six stents on one delivery system) 80, 130 For spot stenting; indicated for treatment of stenoses, occlusions, recoils, and dissections of peripheral arteries, especially for lesions in segments of strong mechanical strain by bending and stretching (eg, popliteal artery)
Boston Scientific Corporation Wallstent Endoprosthesis Elgiloy 6 (2 mm) 0.035 (0.89 mm) 6–10 18, 20, 23, 24, 34, 35, 36, 38, 39, 46, 47, 49, 52, 55, 59, 61, 66, 67, 69 75, 135 Iliac
Boston Scientific Corporation Wallstent Endoprosthesis Elgiloy 6 (2 mm)–12 (4 mm) 0.035 (0.89 mm) 5–8, 10, 12, 14, 16, 18, 20, 22, 24 20, 35, 40, 42, 45, 55, 60, 68, 70, 80, 90, 94 75, 135 (up to 12-mm diameter); 75 (≥ 14-mm diameter) Tracheobronchial
Boston Scientific Corporation Wallstent Endoprosthesis Elgiloy 6 (2 mm)–9 (3 mm) 0.035 (0.89 mm) 8, 10, 12 20, 40, 42, 60, 68, 80, 90, 94 75 Transhepatic biliary
Boston Scientific Corporation Wallstent Endoprosthesis Elgiloy 7 (2.33 mm)–9 (3 mm) 0.035 (0.89 mm) 10, 12 40, 42, 60, 68, 90, 94 75 TIPS
Boston Scientific Corporation Wallstent Endoprosthesis Elgiloy 6 (2 mm)–10 (3.33 mm) 0.035 (0.89 mm) 10, 12, 14, 16 20, 40, 42, 60, 68, 90, 94 75 Central venous
Abbott Xpert Pro Peripheral Self-Expanding Stent System Nitinol 4, 5 0.018 3–6, 8 20, 30, 40, 60, 80, 100 80, 90, 120, 135 Vascular: insufficient result after PTA (eg, residual stenosis, dissection, obstruction due to detached atherosclerotic plaque material or reocclusion); biliary: bile duct obstruction caused by malignant tumors (treated via transhepatic approach); malignancy: (a) patients presenting pancreatic carcinoma, which is compressing the biliary tree, (b) patients presenting cholangiocarcinoma that has led to biliary obstruction, (c) patients presenting an extra-hepatic biliary obstruction due to gallbladder carcinoma, metastases, or ampuliary carcinoma
Rontis AG Zeus SX Nickel titanium alloy (nitinol) 6 0.035 6, 7, 8, 9, 10, 11 20, 40, 60, 80, 100, 120, 150 80, 120 Peripheral arteries
Cook Medical Zilver 518 Vascular Self-Expanding Stent Nitinol 5 0.018 4–10 4 mm: 20, 40, 80 mm; 5–9 mm: 40, 60, 80 mm; 10 mm: 40, 60 mm 80, 125 Iliac arteries
Cook Medical Zilver 635 Biliary Self-Expanding Stent Nitinol 6 0.035 8, 9, 10, 12 40 (only available in 8, 9, 10 mm), 60, 80 40 Palliation of malignant neoplasm in the biliary tree
Cook Medical Zilver 635 Vascular Self-Expanding Stent Nitinol 6 0.035 12, 14 12 mm: 40, 60, 80 mm; 14 mm: 40, 60, 80 mm 80, 125 Iliac arteries
Cook Medical Zilver Flex Vascular Self-Expanding Stent Nitinol 6 0.035 5–10 20, 30, 40, 60, 80, 100, 120, 140; 170, 200 (only available in diameters 5, 6, 7, 8 mm) 80, 125 Iliac and above-the-knee femoropopliteal arteries

Advertisement